Request for Information on the Bioeconomy, 47561-47562 [2019-19470]
Download as PDF
khammond on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 84, No. 175 / Tuesday, September 10, 2019 / Notices
pursuant to an Order of the Commission
or the presiding officer. If you do not
have an NRC-issued digital ID certificate
as described above, click ‘‘Cancel’’
when the link requests certificates and
you will be automatically directed to the
NRC’s electronic hearing dockets where
you will be able to access any publicly
available documents in a particular
hearing docket. Participants are
requested not to include personal
privacy information, such as social
security numbers, home addresses, or
personal phone numbers in their filings,
unless an NRC regulation or other law
requires submission of such
information. For example, in some
instances, individuals provide home
addresses in order to demonstrate
proximity to a facility or site. With
respect to copyrighted works, except for
limited excerpts that serve the purpose
of the adjudicatory filings and would
constitute a Fair Use application,
participants are requested not to include
copyrighted materials in their
submission.
The Commission will issue a notice or
Order granting or denying a hearing
request or intervention petition,
designating the issues for any hearing
that will be held and designating the
Presiding Officer. A notice granting a
hearing will be published in the Federal
Register and served on the parties to the
hearing.
If a person (other than Justin Roberts)
requests a hearing, that person shall set
forth with particularity the manner in
which his interest is adversely affected
by this Order and shall address the
criteria set forth in 10 CFR 2.309(d) and
(f).
If a hearing is requested by a person
whose interest is adversely affected, the
Commission will issue an Order
designating the time and place of any
hearings. If a hearing is held, the issue
to be considered at such hearing shall be
whether this Order should be sustained.
In the absence of any request for
hearing, or written approval of an
extension of time in which to request a
hearing, the provisions specified in
Section IV above shall be final thirty
(30) calendar days from the date of
issuance of this Order without further
order or proceedings. If an extension of
time for requesting a hearing has been
approved, the provisions specified in
Section IV shall be final when the
extension expires if a hearing request
has not been received.
For the Nuclear Regulatory Commission.
George A. Wilson,
Director, Office of Enforcement.
VerDate Sep<11>2014
16:56 Sep 09, 2019
Jkt 247001
Dated this 5th day of September, 2019.
[FR Doc. 2019–19556 Filed 9–9–19; 8:45 am]
BILLING CODE 7590–01–P
OFFICE OF SCIENCE AND
TECHNOLOGY POLICY
Request for Information on the
Bioeconomy
Office of Science and
Technology Policy (OSTP).
ACTION: Notice of request for
information (RFI) for Bioeconomy.
AGENCY:
The Office of Science
Technology and Policy (OSTP) requests
input from all interested parties on the
U.S. Bioeconomy. The Bioeconomy
represents the infrastructure,
innovation, products, technology, and
data derived from biologically-related
processes and science that drive
economic growth, promote health, and
increase public benefit. Through this
Request for Information (RFI), OSTP
seeks input from the public, including
those with capital investments,
performing innovative research, or
developing enabling platforms and
applications in the field of biological
sciences, to include healthcare,
medicine, pharmaceuticals,
biotechnology, manufacturing, energy
production, and agriculture. This RFI
will inform notable gaps,
vulnerabilities, and areas to promote
and protect in the U.S. Bioeconomy that
may benefit from Federal government
attention. The information can include
suggestions on those areas of greatest
priority within the Bioeconomy, as well
as past or future Federal government
efforts to build, promote, and sustain
the U.S. Bioeconomy. The public input
provided in response to this RFI will
inform the Executive Office of the
President as well as private sector,
academia, non-governmental entities,
and other stakeholders with interest in
and expertise relating to the promotion
of a Bioeconomy ecosystem
encompassing shared values and core
American principles.
DATES: Interested persons are invited to
submit comments on or before 11:59
p.m. (ET) on October 22, 2019.
ADDRESSES: Comments submitted in
response to this notice may be
submitted online to:
MBX.OSTP.WHBioeconomy@
ostp.eop.gov. Email submissions should
be machine-readable [pdf, word] and
not be copy-protected. Submissions
should include ‘‘RFI Response:
Bioeconomy’’ in the subject line of the
message.
SUMMARY:
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
47561
Instructions: Response to this RFI is
voluntary. Each individual or institution
is requested to submit only one
response. Submission must not exceed
10 pages in 12 point or larger font, with
a page number provided on each page.
Responses should include the name of
the person(s) or organization(s) filing
the comment. Comments containing
references, studies, research, and other
empirical data that are not widely
published should include copies or
electronic links of the referenced
materials. Comments containing
profanity, vulgarity, threats, or other
inappropriate language or content will
not be considered.
Comments submitted in response to
this notice are subject to FOIA.
Responses to this RFI may also be
posted, without change, on a Federal
website. Therefore, we request that no
business proprietary information,
copyrighted information, or personally
identifiable information be submitted in
response to this RFI.
In accordance with FAR 15–202(3),
responses to this notice are not offers
and cannot be accepted by the
Government to form a binding contract.
Additionally, the U.S. Government will
not pay for response preparation or for
the use of any information contained in
the response.
FOR FURTHER INFORMATION CONTACT:
Paige Waterman at:
MBX.OSTP.WHBioeconomy@
ostp.eop.gov.
SUPPLEMENTARY INFORMATION: A
prosperous bioeconomy provides a host
of opportunities for the current and
future growth of all sectors of the U.S.
economy. Today, the Bioeconomy
ecosystem in the United States is a
rapidly changing technological and
economic environment. Data rights,
analysis, use, storage and security are all
critical components of biotechnology,
healthcare, medicine, public health,
data science, energy, environment, and
agriculture. Ongoing research and
innovation in these areas provide the
foundation for solving the problems of
today and the potentially unforeseen
issues of tomorrow. To that end,
stimulating the research enterprise,
developing and sustaining workforce
talent, and supporting the infrastructure
for the manufacturing of products
remain critical components to any
Bioeconomy objective.
To inform the Federal government’s
decision-making and establish the
Nation’s guiding values and principles
in the promotion and protection of the
U.S. Bioeconomy, OSTP seeks public
input on how U.S. Government action
regarding the Bioeconomy can support
E:\FR\FM\10SEN1.SGM
10SEN1
khammond on DSKBBV9HB2PROD with NOTICES
47562
Federal Register / Vol. 84, No. 175 / Tuesday, September 10, 2019 / Notices
scientific discovery, the development of
technological advances, and increase
the impact of a vibrant bioeconomy on
the Nation’s vitality and our citizens’
lives. To that end, responders are
specifically requested to answer one or
more of the following questions in their
submissions. Consortia responses are
also encouraged.
1. What specific actions could the
U.S. Government take to reinforce a
values-based ecosystem that will guide
the transformation and expansion of the
U.S. Bioeconomy, in both the short- and
long-term? Please consider:
a. Policy or regulatory opportunities
and gaps throughout the continuum of
basic science translation, product
development and commercialization;
b. Scientific areas where research
funding could be strategically targeted
to stimulate discovery;
c. Novel public-private partnership
mechanisms;
d. International opportunities;
e. Challenges to taking identified
actions or implementing change.
2. In what ways can the U.S.
Government partner with the private
sector, industry, professional
organizations, and academia to ensure
the training and continued development
of a skilled workforce to support the
growth of the Bioeconomy? Please
consider:
a. Potential needs and solutions at the
skilled technical, undergraduate,
professional master’s program or
graduate level;
b. Specific needs within basic science,
translational research, product
development, and commercialization;
c. Approaches for the development of
non-traditional, multi-disciplinary
educational backgrounds that address
the convergent nature of emerging
technologies and integrate core values
including safety and security;
d. Effective geographic distribution of
workforce and talent development
across the United States;
e. The development of a public and
private ecosystem that will attract and
retain domestic and foreign talent
within the United States at all skill
levels.
3. In what ways can the U.S.
Government partner with the private
sector, industry, professional
organizations, and academia to establish
a more robust and efficient Bioeconomy
infrastructure? Please consider:
a. Current infrastructure—from
databases to world-class technology and
manufacturing capabilities;
b. Geographic distribution of
manufacturing capabilities compared to
future manufacturing needs;
c. Leveraging existing public-private
partnerships and identifying trusted
VerDate Sep<11>2014
16:56 Sep 09, 2019
Jkt 247001
information sharing mechanisms to
accelerate innovation and facilitate
fruitful, equitable domestic and
international collaborations;
d. Institutional models for achieving
translation of basic science discoveries
to application and/or entry into the
marketplace.
4. Across the spectrum, from basic
discovery to practical application, what
data policies, information-sharing
mechanisms, and safeguards will be
necessary for a prosperous U.S.
Bioeconomy? Please consider:
a. Scientific, regulatory,
manufacturing standards and/or
benchmarks and/or best practices
around data that should be developed to
best accelerate Bioeconomy growth;
b. Possible safeguards for technology,
data, and emergent products, such as
patent/intellectual property protection,
data quality and provenance validation,
and privacy and security assurances.
Sean Bonyun,
Chief of Staff, Office of Science and
Technology Policy.
[FR Doc. 2019–19470 Filed 9–9–19; 8:45 am]
BILLING CODE 3270–F9–P
SECURITIES AND EXCHANGE
COMMISSION
[Investment Company Act Release No.
33616; File No. 812–14988]
Diamond Hill Funds and Diamond Hill
Capital Management, Inc.
September 4, 2019.
Securities and Exchange
Commission (‘‘Commission’’).
ACTION: Notice.
AGENCY:
Notice of an application for an order
pursuant to: (a) Section 6(c) of the
Investment Company Act of 1940
(‘‘Act’’) granting an exemption from
sections 18(f) and 21(b) of the Act; (b)
section 12(d)(1)(J) of the Act granting an
exemption from section 12(d)(1) of the
Act; (c) sections 6(c) and 17(b) of the
Act granting an exemption from sections
17(a)(1), 17(a)(2) and 17(a)(3) of the Act;
and (d) section 17(d) of the Act and rule
17d–1 under the Act to permit certain
joint arrangements and transactions.
Applicants request an order that would
permit certain registered open-end
management investment companies to
participate in a joint lending and
borrowing facility.
APPLICANTS: Diamond Hill Funds,
established as a business trust under the
laws of Ohio and registered under the
Act as an open-end management
investment company with multiple
series, and Diamond Hill Capital
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Management, Inc. (the ‘‘Adviser’’), an
Ohio corporation registered as an
investment adviser under the
Investment Advisers Act of 1940.
FILING DATES: The application was filed
on December 19, 2018, and amended on
May 17, 2019.
HEARING OR NOTIFICATION OF HEARING:
An order granting the requested relief
will be issued unless the Commission
orders a hearing. Interested persons may
request a hearing by writing to the
Commission’s Secretary and serving
applicants with a copy of the request,
personally or by mail. Hearing requests
should be received by the Commission
by 5:30 p.m. on September 30, 2019 and
should be accompanied by proof of
service on the applicants, in the form of
an affidavit, or, for lawyers, a certificate
of service. Pursuant to Rule 0–5 under
the Act, hearing requests should state
the nature of the writer’s interest, any
facts bearing upon the desirability of a
hearing on the matter, the reason for the
request, and the issues contested.
Persons who wish to be notified of a
hearing may request notification by
writing to the Commission’s Secretary.
ADDRESSES: Secretary, U.S. Securities
and Exchange Commission, 100 F Street
NE, Washington, DC 20549–1090;
Applicants: Diamond Hill Funds and
Diamond Hill Capital Management, Inc.,
325 John H. McConnell Blvd., Suite 200,
Columbus, Ohio 43215.
FOR FURTHER INFORMATION CONTACT:
Kieran G. Brown, Senior Counsel, at
202–551–6773, or David J. Marcinkus,
Branch Chief, at (202) 551–6821
(Division of Investment Management,
Chief Counsel’s Office).
SUPPLEMENTARY INFORMATION: The
following is a summary of the
application. The complete application
may be obtained via the Commission’s
website by searching for the file
number, or an applicant using the
Company name box, at https://
www.sec.gov/search/search.htm or by
calling (202) 551–8090.
Summary of the Application
1. Applicants request an order that
would permit the applicants to
participate in an interfund lending
facility where each Fund could lend
money directly to and borrow money
directly from other Funds to cover
unanticipated cash shortfalls, such as
unanticipated redemptions or trade
fails.1 The Funds will not borrow under
1 Applicants request that the order apply to the
applicants and to any other registered open-end
management investment company or series thereof
(each, a ‘‘Fund’’ and collectively, the ‘‘Funds’’) for
which the Adviser or any successor-in-interest
thereto or an investment adviser controlling,
E:\FR\FM\10SEN1.SGM
10SEN1
Agencies
[Federal Register Volume 84, Number 175 (Tuesday, September 10, 2019)]
[Notices]
[Pages 47561-47562]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19470]
=======================================================================
-----------------------------------------------------------------------
OFFICE OF SCIENCE AND TECHNOLOGY POLICY
Request for Information on the Bioeconomy
AGENCY: Office of Science and Technology Policy (OSTP).
ACTION: Notice of request for information (RFI) for Bioeconomy.
-----------------------------------------------------------------------
SUMMARY: The Office of Science Technology and Policy (OSTP) requests
input from all interested parties on the U.S. Bioeconomy. The
Bioeconomy represents the infrastructure, innovation, products,
technology, and data derived from biologically-related processes and
science that drive economic growth, promote health, and increase public
benefit. Through this Request for Information (RFI), OSTP seeks input
from the public, including those with capital investments, performing
innovative research, or developing enabling platforms and applications
in the field of biological sciences, to include healthcare, medicine,
pharmaceuticals, biotechnology, manufacturing, energy production, and
agriculture. This RFI will inform notable gaps, vulnerabilities, and
areas to promote and protect in the U.S. Bioeconomy that may benefit
from Federal government attention. The information can include
suggestions on those areas of greatest priority within the Bioeconomy,
as well as past or future Federal government efforts to build, promote,
and sustain the U.S. Bioeconomy. The public input provided in response
to this RFI will inform the Executive Office of the President as well
as private sector, academia, non-governmental entities, and other
stakeholders with interest in and expertise relating to the promotion
of a Bioeconomy ecosystem encompassing shared values and core American
principles.
DATES: Interested persons are invited to submit comments on or before
11:59 p.m. (ET) on October 22, 2019.
ADDRESSES: Comments submitted in response to this notice may be
submitted online to: [email protected]. Email
submissions should be machine-readable [pdf, word] and not be copy-
protected. Submissions should include ``RFI Response: Bioeconomy'' in
the subject line of the message.
Instructions: Response to this RFI is voluntary. Each individual or
institution is requested to submit only one response. Submission must
not exceed 10 pages in 12 point or larger font, with a page number
provided on each page. Responses should include the name of the
person(s) or organization(s) filing the comment. Comments containing
references, studies, research, and other empirical data that are not
widely published should include copies or electronic links of the
referenced materials. Comments containing profanity, vulgarity,
threats, or other inappropriate language or content will not be
considered.
Comments submitted in response to this notice are subject to FOIA.
Responses to this RFI may also be posted, without change, on a Federal
website. Therefore, we request that no business proprietary
information, copyrighted information, or personally identifiable
information be submitted in response to this RFI.
In accordance with FAR 15-202(3), responses to this notice are not
offers and cannot be accepted by the Government to form a binding
contract. Additionally, the U.S. Government will not pay for response
preparation or for the use of any information contained in the
response.
FOR FURTHER INFORMATION CONTACT: Paige Waterman at:
[email protected].
SUPPLEMENTARY INFORMATION: A prosperous bioeconomy provides a host of
opportunities for the current and future growth of all sectors of the
U.S. economy. Today, the Bioeconomy ecosystem in the United States is a
rapidly changing technological and economic environment. Data rights,
analysis, use, storage and security are all critical components of
biotechnology, healthcare, medicine, public health, data science,
energy, environment, and agriculture. Ongoing research and innovation
in these areas provide the foundation for solving the problems of today
and the potentially unforeseen issues of tomorrow. To that end,
stimulating the research enterprise, developing and sustaining
workforce talent, and supporting the infrastructure for the
manufacturing of products remain critical components to any Bioeconomy
objective.
To inform the Federal government's decision-making and establish
the Nation's guiding values and principles in the promotion and
protection of the U.S. Bioeconomy, OSTP seeks public input on how U.S.
Government action regarding the Bioeconomy can support
[[Page 47562]]
scientific discovery, the development of technological advances, and
increase the impact of a vibrant bioeconomy on the Nation's vitality
and our citizens' lives. To that end, responders are specifically
requested to answer one or more of the following questions in their
submissions. Consortia responses are also encouraged.
1. What specific actions could the U.S. Government take to
reinforce a values-based ecosystem that will guide the transformation
and expansion of the U.S. Bioeconomy, in both the short- and long-term?
Please consider:
a. Policy or regulatory opportunities and gaps throughout the
continuum of basic science translation, product development and
commercialization;
b. Scientific areas where research funding could be strategically
targeted to stimulate discovery;
c. Novel public-private partnership mechanisms;
d. International opportunities;
e. Challenges to taking identified actions or implementing change.
2. In what ways can the U.S. Government partner with the private
sector, industry, professional organizations, and academia to ensure
the training and continued development of a skilled workforce to
support the growth of the Bioeconomy? Please consider:
a. Potential needs and solutions at the skilled technical,
undergraduate, professional master's program or graduate level;
b. Specific needs within basic science, translational research,
product development, and commercialization;
c. Approaches for the development of non-traditional, multi-
disciplinary educational backgrounds that address the convergent nature
of emerging technologies and integrate core values including safety and
security;
d. Effective geographic distribution of workforce and talent
development across the United States;
e. The development of a public and private ecosystem that will
attract and retain domestic and foreign talent within the United States
at all skill levels.
3. In what ways can the U.S. Government partner with the private
sector, industry, professional organizations, and academia to establish
a more robust and efficient Bioeconomy infrastructure? Please consider:
a. Current infrastructure--from databases to world-class technology
and manufacturing capabilities;
b. Geographic distribution of manufacturing capabilities compared
to future manufacturing needs;
c. Leveraging existing public-private partnerships and identifying
trusted information sharing mechanisms to accelerate innovation and
facilitate fruitful, equitable domestic and international
collaborations;
d. Institutional models for achieving translation of basic science
discoveries to application and/or entry into the marketplace.
4. Across the spectrum, from basic discovery to practical
application, what data policies, information-sharing mechanisms, and
safeguards will be necessary for a prosperous U.S. Bioeconomy? Please
consider:
a. Scientific, regulatory, manufacturing standards and/or
benchmarks and/or best practices around data that should be developed
to best accelerate Bioeconomy growth;
b. Possible safeguards for technology, data, and emergent products,
such as patent/intellectual property protection, data quality and
provenance validation, and privacy and security assurances.
Sean Bonyun,
Chief of Staff, Office of Science and Technology Policy.
[FR Doc. 2019-19470 Filed 9-9-19; 8:45 am]
BILLING CODE 3270-F9-P